Loading...
Gestational changes in buprenorphine exposure: A physiologically‐based pharmacokinetic analysis
AIMS: Buprenorphine (BUP) is approved by the US Food and Drug Administration for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for nonpregnant adults. However, physiological changes during pregnancy may alter BUP exposure...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089832/ https://ncbi.nlm.nih.gov/pubmed/29873094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13642 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|